Europe’s COVID-19 Spending Spree Unmasked

ER Editor: Hydroxychloroquine / chloroquine demand was part of this ‘spending spree’. Publishing as we have done many doctors who have clinically proven the value of this drug, we don’t endorse these journalists’ position on the drug.


Europe’s COVID-19 Spending Spree Unmasked


As countries across Europe went into lockdown earlier this year to fight the COVID-19 pandemic, there was one early and obvious casualty: transparency. In the rush to obtain critical supplies, many countries suspended their usual public procurement rules, resulting in billions of euros of spending that remains largely hidden from the public.

So we at the Organized Crime and Corruption Reporting Project (OCCRP) decided to find out what happened to that money.

Along with media partners in 37 countries, we collected information from over 37,800 COVID-19 related tenders and contracts worth over 21 billion euros (U.S $24.9 billion), running from February to October this year. They cover key goods such as personal protective equipment (PPE), ventilators, tests, and medications.


What we found was often fascinating. Governments bought respirator masks at prices that varied wildly, from just 20 cents per unit to 37 euros each. The pandemic also prompted a boom for hydroxychloroquine and chloroquine, controversial drugs promoted by many as a miracle treatment for COVID-19, despite limited evidence (ER: not true). Data obtained by reporters showed the number of large contracts for these drugs increased 15-fold so far this year. Dexamethasone, a steroid that has met with more clinical success, saw a 36-fold increase.

You can browse the data yourself at our interactive here.

The data is far from complete, but it gives an unprecedented view of just what Europe’s governments have been spending their billions on — and where things may have gone astray.

Bargains and Black Holes

The data we obtained gives just a snapshot of Europe’s COVID-19 spending. We pulled data from the European Union’s procurement portal, Tenders Electronic Daily, and national and regional governments.

The number of contracts we obtained from each country reflected its level of transparency, not necessarily how much it spent.

We obtained the most contracts, roughly 15,000, from Portugal. Despite its relatively small size, it was one of the few European countries to publish all its contracts online, along with an overview of its COVID-19 related purchases.The runner-up, with 12,000 contracts, was Russia.

Other countries have been virtual black holes of information. Belgium, the Netherlands, and Denmark rejected reporters’ data requests outright, typically arguing that it was necessary to preserve secrecy so as to not undermine negotiations for the purchase of goods. In response to a freedom-of-information request, Norway provided some details on contracts, such as company names, but would not give price information.

Big Contracts, Little Competition

The 20.8 billion euros’ worth of contracts that we collected included some very big deals.

Nearly half the total (10 billion euros) are contracts from the U.K., including a series of PPE purchases by the Department of Health and Social Care for 4.9 billion euros.

The largest single national contract was in Spain, where the government bought 181 million euros’ worth of PPE in a no-bid deal.

We obtained 3.4 billion euros’ worth of tenders from the European Commission on joint procurement and two billion euros of tenders from Germany.

Click here to scroll through the interactive map.



Featured image is from NATO


The Liberty Beacon Project is now expanding at a near exponential rate, and for this we are grateful and excited! But we must also be practical. For 7 years we have not asked for any donations, and have built this project with our own funds as we grew. We are now experiencing ever increasing growing pains due to the large number of websites and projects we represent. So we have just installed donation buttons on our websites and ask that you consider this when you visit them. Nothing is too small. We thank you for all your support and your considerations … (TLB)


Comment Policy: As a privately owned web site, we reserve the right to remove comments that contain spam, advertising, vulgarity, threats of violence, racism, or personal/abusive attacks on other users. This also applies to trolling, the use of more than one alias, or just intentional mischief. Enforcement of this policy is at the discretion of this websites administrators. Repeat offenders may be blocked or permanently banned without prior warning.


Disclaimer: TLB websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.


Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.